The Prognostic Significance of Nodal Disease Burden in Patients with Lymph Node Metastases from Renal Cell Carcinoma

Overview

Journal Urol Oncol

Publisher Elsevier

Date 2019 Mar 4

PMID 30826169

Citations 6

Authors

Piotr Zareba

Paul Russo

Affiliations

Soon will be listed here.

Abstract

Objectives: To assess the relationship between nodal disease burden and overall survival (OS) among patients with lymph node (LN) metastases from renal cell carcinoma (RCC) METHODS: The National Cancer Data Base was used to identify 2,975 patients with RCC who were treated with radical nephrectomy and were found to have regional LN metastases. Associations between the number of positive and negative LN removed and OS were assessed using Cox proportional hazards regression. The median follow-up time among survivors was 3.6years.

Results: The median number of positive LN was 1 (interquartile range 1-3). A higher number of positive LN was associated with higher all-cause mortality on multivariable analysis (HR 1.06 per 1 positive LN, 95% CI 1.04, 1.07, P < 0.001). Conversely, higher negative LN counts were associated with better OS (HR 0.97 per 1 negative LN, 95% CI 0.96, 0.99, P < 0.001). The adjusted probability of a patient with 1 LN removed that was positive surviving at least 2 years was 56%, a figure that increased to 64% when 1 out of 10 LN removed was positive and decreased to 38% when 10 out of 10 LN removed were positive.

Conclusions: Ours is the first study to show that differences in nodal disease burden translate into clinically significant differences in survival among patients with LN metastases from RCC.

Citing Articles

Therapeutic options for different metastatic sites arising from renal cell carcinoma: A review.

Wang X, Qian L, Qian Z, Wu Q, Cheng D, Wei J Medicine (Baltimore). 2024; 103(21):e38268.

PMID: 38788027 PMC: 11124732. DOI: 10.1097/MD.0000000000038268.

The Current Role of Lymph Node Dissection in Nonmetastatic Localized Renal Cell Carcinoma.

Ngai M, Chandrasekar T, Bratslavsky G, Goldberg H J Clin Med. 2023; 12(11).

PMID: 37297925 PMC: 10253302. DOI: 10.3390/jcm12113732.

Development and validation of a machine learning model to predict the risk of lymph node metastasis in renal carcinoma.

Feng X, Hong T, Liu W, Xu C, Li W, Yang B Front Endocrinol (Lausanne). 2022; 13:1054358.

PMID: 36465636 PMC: 9716136. DOI: 10.3389/fendo.2022.1054358.

Prognostic significance of pathologic nodal positivity in non-metastatic patients with renal cell carcinoma who underwent radical or partial nephrectomy.

Kim S, Park B, Hwang E, Hong S, Jeong C, Kwak C Sci Rep. 2021; 11(1):3079.

PMID: 33542395 PMC: 7862313. DOI: 10.1038/s41598-021-82750-y.

Is nodal disease burden relevant in patients with renal cell carcinoma and lymph node invasion?.

Rodriguez-Covarrubias F Ann Transl Med. 2019; 7(Suppl 3):S149.

PMID: 31576356 PMC: 6685840. DOI: 10.21037/atm.2019.06.31.

References

Karakiewicz P, Trinh Q, Bhojani N, Bensalah K, Salomon L, De La Taille A . Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival. Eur Urol. 2007; 51(6):1616-24. DOI: 10.1016/j.eururo.2006.12.015. View

Capitanio U, Jeldres C, Patard J, Perrotte P, Zini L, De La Taille A . Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma. BJU Int. 2008; 103(1):33-7. DOI: 10.1111/j.1464-410X.2008.08014.x. View

Trinh Q, Schmitges J, Bianchi M, Sun M, Shariat S, Sammon J . Node-positive renal cell carcinoma in the absence of distant metastases: predictors of cancer-specific mortality in a population-based cohort. BJU Int. 2011; 110(2 Pt 2):E21-7. DOI: 10.1111/j.1464-410X.2011.10701.x. View

Ficarra V, Righetti R, Pilloni S, DAmico A, Maffei N, Novella G . Prognostic factors in patients with renal cell carcinoma: retrospective analysis of 675 cases. Eur Urol. 2002; 41(2):190-8. DOI: 10.1016/s0302-2838(01)00027-6. View

Delacroix Jr S, Chapin B, Chen J, Nogueras-Gonzalez G, Tamboli P, Matin S . Can a durable disease-free survival be achieved with surgical resection in patients with pathological node positive renal cell carcinoma?. J Urol. 2011; 186(4):1236-41. DOI: 10.1016/j.juro.2011.05.051. View

Crispen P, Breau R, Allmer C, Lohse C, Cheville J, Leibovich B . Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates. Eur Urol. 2010; 59(1):18-23. DOI: 10.1016/j.eururo.2010.08.042. View

Terrone C, Cracco C, Porpiglia F, Bollito E, Scoffone C, Poggio M . Reassessing the current TNM lymph node staging for renal cell carcinoma. Eur Urol. 2006; 49(2):324-31. DOI: 10.1016/j.eururo.2005.11.014. View

Sun M, Bianchi M, Hansen J, Abdollah F, Trinh Q, Lughezzani G . Nodal involvement at nephrectomy is associated with worse survival: a stage-for-stage and grade-for-grade analysis. Int J Urol. 2012; 20(4):372-80. DOI: 10.1111/j.1442-2042.2012.03170.x. View

Kroeger N, Pantuck A, Wells J, Lawrence N, Broom R, Kim J . Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies. Eur Urol. 2014; 68(3):506-15. DOI: 10.1016/j.eururo.2014.11.054. View

10.

Berger A, Sigurdson E, Levoyer T, Hanlon A, Mayer R, Macdonald J . Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol. 2005; 23(34):8706-12. DOI: 10.1200/JCO.2005.02.8852. View

11.

Vinh-Hung V, Verkooijen H, Fioretta G, Neyroud-Caspar I, Rapiti E, Vlastos G . Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol. 2009; 27(7):1062-8. DOI: 10.1200/JCO.2008.18.6965. View

12.

Gershman B, Moreira D, Thompson R, Boorjian S, Lohse C, Costello B . Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection. Eur Urol. 2017; 72(2):300-306. DOI: 10.1016/j.eururo.2016.12.027. View

13.

Kates M, Lavery H, Brajtbord J, Samadi D, Palese M . Decreasing rates of lymph node dissection during radical nephrectomy for renal cell carcinoma. Ann Surg Oncol. 2012; 19(8):2693-9. DOI: 10.1245/s10434-012-2330-6. View

14.

Johnsen J, Hellsten S . Lymphatogenous spread of renal cell carcinoma: an autopsy study. J Urol. 1997; 157(2):450-3. View